Unlocking AI driven outbound for life sciences: how Ooho expanded Its value proposition with Revenanas

Ooho’s expertise in branding, content creation, and distribution positioned them as a trusted partner for biotech and medtech companies. However, their clients faced mounting challenges.
‍

• Audience Overload: Hospital, pharma, and lab decision makers were flooded with LinkedIn messages, full inboxes, and rising ad costs.
  ‍
• High Cost per Lead: Traditional outreach was becoming less effective, with costs increasing rapidly.
  ‍
• Difficulty Scaling: Ooho experimented with small scale cold outreach, targeting signals such as new funding rounds or niche research activities, but lacked the systems to scale these efforts.
  ‍

The challenge was clear: We needed to build an automated engine that could systematically find the right, hard-to-find contacts at their target hospitals and enrich them with data for meaningful personalization

Working with Revenanas, Ooho added a fourth growth pillar to its offering. Together, we designed a scalable process.
‍

1. Signal Based Targeting: Identifying high value triggers such as funding events and research initiatives to prioritize outreach.
   ‍
2. Tool Integration: Leveraging platforms such as Clay and Lemlist to automate discovery, enrichment, and personalized campaigns.
   ‍
3. Message Relevance: Combining Ooho’s scientific content expertise with AI driven personalization ensured messages resonated with highly technical audiences.
   ‍
4. Outbound at Scale: Turning what was once a small experiment into a repeatable, automated system that expanded Ooho’s ability to reach otherwise hard to access stakeholders.

By integrating outbound automation with their core marketing services, Ooho achieved the following.

• Expanded Services:
  ‍Added outbound and AI driven prospecting as a new pillar alongside branding, content, and distribution.
  ‍
• Increased Relevance:
  Delivered messages tailored to technical roles such as preclinical trials or target discovery, speaking directly to scientists and decision makers.
  ‍
• Differentiated Value:
  ‍Stood outing a crowded market by helping clients break through digital noise with highly relevant outreach.
  ‍
• Future Proofed Offering:
  ‍Positioned themselves ahead of the curve as biotech and dmed tech companies increasingly demand AI driven go to market strategies.